Equillium (NASDAQ: EQ) wins approval for 1-for-20 split and 400M authorized shares
Rhea-AI Filing Summary
Equillium, Inc. reported results of its 2026 Annual Meeting of Stockholders. Shareholders holding 54,287,329 shares, or 85.86% of the 63,226,556 shares outstanding as of April 1, 2026, were present or represented by proxy.
Stockholders elected Charles McDermott and Bruce Steel as Class II directors to serve until the 2029 annual meeting. Former director Peter Colabuono was not renominated, and the board size was reduced from seven to six directors.
Shareholders approved an amendment allowing a potential reverse stock split of the common stock at a ratio between 1-for-2 and 1-for-20, to be implemented at the board’s discretion. They also approved increasing authorized common shares from 200,000,000 to 400,000,000 and ratified Crowe LLP as independent auditor for the year ending December 31, 2026.
Positive
- None.
Negative
- None.
Insights
Shareholders approved flexible reverse split authority and doubled authorized shares.
Equillium’s investors endorsed tools that give the board significant flexibility over the capital structure. Approval to execute a reverse stock split in a range from 1-for-2 to 1-for-20 lets directors adjust the share price and share count if they decide conditions warrant it.
Increasing authorized common stock from 200,000,000 to 400,000,000 expands the capacity for future equity issuance, acquisitions, or incentive plans, though no specific transactions are described. These changes were approved alongside routine items like director elections and auditor ratification, so the actual impact depends on how the board uses the new flexibility over time.
8-K Event Classification
AI-generated analysis. How Rhea-AI works. Not financial advice.
